Community Healthcare Trust Announces Fourth Quarter Earnings Release Date And Conference Call

Community Healthcare Trust Incorporated (NYSE: CHCT) has announced the release date and conference call details for its fourth quarter 2024 earnings. The company will report its results on Tuesday, February 18, 2025, after market close, and will hold a conference call to discuss the earnings on Wednesday, February 19, 2025, at 9:00 a.m. Central Time. The call will be accessible via domestic and international dial-in numbers, as well as a webcast available at the company's website under the Investor Relations section.

CHCT's fourth quarter earnings release and conference call provide an opportunity for investors to gain insights into the company's financial performance and outlook. The company's stock price has been volatile in recent months, and investors may be looking for signs of stability or growth in the healthcare real estate sector. The earnings call will also give investors a chance to ask questions and engage with the company's management team.

In addition to the earnings release and conference call, CHCT has recently announced an increase in its quarterly dividend, effective for the third quarter ended September 30, 2024. The company's dividend yield is currently 9.44%, which is competitive with other healthcare REITs. The dividend increase reflects the company's strong financial performance and commitment to returning value to shareholders.



CHCT's stock price has been volatile in recent months, with a 52-week price change of -24.65%. The company's beta is 0.66, indicating that its price volatility has been lower than the market average. The stock's relative strength index (RSI) is 60.78, which suggests that it may be in a neutral or slightly bullish position. The average volume for the stock over the past 20 days is 268,282 shares.



CHCT's financial performance has been strong in recent quarters, with revenue growth of 14.9% in the fourth quarter of 2023 compared to the same period in 2022. The company's earnings per share (EPS) for the same period were $0.61, compared to $0.19 in the fourth quarter of 2022. The company's revenue and EPS for the full year 2023 were $112.85 million and $2.49, respectively.

CHCT's dividend history shows a consistent increase in the cash amount and percentage change over the past decade. The company's annual dividend has grown from $0.4575 in 2021 to $1.86 in 2024, representing an average annual growth rate of 2.21%. The company's payout ratio is not provided, but its dividend yield of 9.44% is competitive with other healthcare REITs.



CHCT's balance sheet shows a current ratio of 4.87 and a quick ratio of 2.68, indicating strong liquidity. The company's debt-to-equity ratio is 1.00, and its debt-to-EBITDA ratio is 7.51, suggesting that its debt levels are manageable. The company's interest coverage ratio is 0.99, indicating that it may struggle to meet its interest payments in the short term.

CHCT's return on equity (ROE) is -0.09%, and its return on invested capital (ROIC) is 1.47%. The company's revenue per employee is $3.12 million, and its profits per employee are -$85,000. The company's asset turnover ratio is 0.12, indicating that it may not be efficiently utilizing its assets.

CHCT's Altman Z-Score and Piotroski F-Score are not provided, but the company's Snowflake Score is 3 out of 6, indicating that it may have some financial health risks. The company's valuation ratios, such as the price-to-earnings (P/E) ratio and the price-to-book value (P/BV) ratio, are not provided, but its enterprise value (EV) to earnings before interest, taxes, depreciation, and amortization (EBITDA) ratio is 16.00, and its EV to free cash flow (FCF) ratio is 17.73, suggesting that the company may be overvalued.



In conclusion, CHCT's fourth quarter earnings release and conference call provide an opportunity for investors to gain insights into the company's financial performance and outlook. The company's strong dividend history, competitive dividend yield, and solid financial performance suggest that it may be a attractive investment opportunity. However, the company's volatile stock price, manageable debt levels, and potential financial health risks should be considered before making an investment decision.